Journal of Cardiovascular Disease Research
HUNT FOR BIOMARKER OF CARCINOMA BREAST: ANTINUCLEAR ANTIBODIES
Dr. S. Gowri, Dr. M. Govindan, Dr. T.G. Aruljothi, Dr. S. Poongodi @ Lakshmi
JCDR. 2024: 970-977
Abstract
Background: Carcinoma breast is the second most common malignancy among women which evolves silently and ends in devastation. Tumor cell death induces antinuclear antibody (ANA) production that can be measured by enzyme linked immunosorbent assay (ELISA). Hence this study was undertaken to determine the utility of ANA ELISA in early diagnosis of carcinoma breast.
» PDF